Gilead Sciences Inc. got hit with a $2.5 billion verdict in a patent jury trial against Idenix Pharmaceuticals LLC last year.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.